Livzon Pharmaceutical Group Inc (000513) — Cash Flow Quality Index
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Quality Index of 2.32x as of December 2025. Operating cash flow of CN¥625.70 Million exceeds net income of CN¥269.15 Million, indicating high earnings quality where cash backs reported profits. Explore Livzon Pharmaceutical Group Inc (000513) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Livzon Pharmaceutical Group Inc Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Livzon Pharmaceutical Group Inc across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Livzon Pharmaceutical Group Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Livzon Pharmaceutical Group Inc (1998–2025)
Year-by-year earnings quality comparison for Livzon Pharmaceutical Group Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | CN¥3.18 Billion | CN¥2.02 Billion | ▲ +21.6% |
| 2024 | 1.29x | CN¥2.98 Billion | CN¥2.30 Billion | ▼ -24.5% |
| 2023 | 1.71x | CN¥3.25 Billion | CN¥1.90 Billion | ▲ +20.8% |
| 2022 | 1.42x | CN¥2.77 Billion | CN¥1.96 Billion | ▲ +45.5% |
| 2021 | 0.97x | CN¥1.90 Billion | CN¥1.95 Billion | ▼ -3.9% |
| 2020 | 1.01x | CN¥2.16 Billion | CN¥2.13 Billion | ▼ -16.2% |
| 2019 | 1.21x | CN¥1.77 Billion | CN¥1.46 Billion | ▲ +3.2% |
| 2018 | 1.17x | CN¥1.27 Billion | CN¥1.08 Billion | ▲ +294.2% |
| 2017 | 0.30x | CN¥1.32 Billion | CN¥4.43 Billion | ▼ -81.8% |
| 2016 | 1.63x | CN¥1.28 Billion | CN¥784.35 Million | ▲ +9.5% |
| 2015 | 1.49x | CN¥927.79 Million | CN¥622.64 Million | ▲ +15.0% |
| 2014 | 1.30x | CN¥717.39 Million | CN¥553.62 Million | ▲ +54.3% |
| 2013 | 0.84x | CN¥439.99 Million | CN¥523.99 Million | ▼ -32.8% |
| 2012 | 1.25x | CN¥593.96 Million | CN¥475.22 Million | ▼ -31.6% |
| 2011 | 1.83x | CN¥708.20 Million | CN¥387.80 Million | ▲ +30.5% |
| 2010 | 1.40x | CN¥633.30 Million | CN¥452.49 Million | ▲ +45.3% |
| 2009 | 0.96x | CN¥494.88 Million | CN¥513.79 Million | ▼ -79.7% |
| 2008 | 4.73x | CN¥345.18 Million | CN¥72.91 Million | ▲ +896.9% |
| 2007 | 0.47x | CN¥248.55 Million | CN¥523.38 Million | ▼ -68.7% |
| 2006 | 1.52x | CN¥226.46 Million | CN¥149.33 Million | ▲ +9.5% |
| 2005 | 1.39x | CN¥161.07 Million | CN¥116.27 Million | ▲ +2.9% |
| 2004 | 1.35x | CN¥181.46 Million | CN¥134.74 Million | ▼ -45.5% |
| 2003 | 2.47x | CN¥300.01 Million | CN¥121.47 Million | ▼ -0.2% |
| 2002 | 2.48x | CN¥213.65 Million | CN¥86.32 Million | ▲ +19.2% |
| 2001 | 2.08x | CN¥155.15 Million | CN¥74.71 Million | ▲ +39.7% |
| 2000 | 1.49x | CN¥38.52 Million | CN¥25.90 Million | ▼ -94.5% |
| 1999 | 27.25x | CN¥246.23 Million | CN¥9.04 Million | ▲ +6209.8% |
| 1998 | -0.45x | CN¥-18.21 Million | CN¥40.83 Million | — |